Form 4: Cigna Group SVP Mary T. Agoglia Hoeltzel Executes Stock Option and Sells Shares
SEC Form 4
Mary T. Agoglia Hoeltzel, SVP Tax & Chief Accounting Officer of Cigna Group, exercised stock options and sold shares on May 14, 2024.
Summary
- On May 14, 2024, Mary T. Agoglia Hoeltzel, SVP Tax & Chief Accounting Officer of Cigna Group, exercised an employee stock option to acquire 5,946 shares of Cigna Group common stock at a price of $120.895 per share.
- Simultaneously, she sold 5,946 shares of common stock at a weighted average price of $348.7133, with prices ranging from $348.68 to $349.01 per share.
- Following these transactions, Ms. Agoglia Hoeltzel directly owns 2,594.738 shares of Cigna Group common stock.
- She also continues to hold an employee stock option for 0.0000 shares.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing an executive's stock transactions, which carries a neutral sentiment.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, which are common among corporate executives as part of their compensation packages. These transactions are closely monitored by investors for insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Executive stock option exercises and sales are a standard part of compensation in publicly traded companies like Cigna.
- Comparing the vesting schedule (three equal annual installments) and option terms (expiration 10 years after grant) to those of peers such as UnitedHealth Group or Anthem (now Elevance Health) would provide context on the competitiveness of Cigna's executive compensation.
- The weighted average sale price achieved is within a normal range for market fluctuations.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders.
- Shareholders may view insider transactions as a signal of management's confidence (or lack thereof) in the company's future prospects, although single transactions are not necessarily indicative of a trend.
Key Dates
| Date | Description |
|---|---|
| 02/25/2015 | Date the employee stock option was granted. |
| 02/25/2016 | First vesting date of the employee stock option. |
| 05/14/2024 | Date of stock option exercise and share sale. |
| 05/16/2024 | Date of signature on the Form 4 filing. |
| 02/25/2025 | Expiration date of the employee stock option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.